A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late.  The MPP-brokered sublicences follow on from an agreement between … Continue reading Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates